Drugs / CTX
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02070523 Background | Dec 2013 → Nov 2015 | acute lymphoblastic leukemia | Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | “CTX 800 mg/m2 ivdrip(d1)” NCT02070523 ↗ |
| Route | Intravenous | “CTX 800 mg/m2 ivdrip(d1)” NCT02070523 ↗ |